Home/Filings/4/0000899243-18-031054
4//SEC Filing

Verner Erik J. 4

Accession 0000899243-18-031054

CIK 0001626971other

Filed

Dec 13, 7:00 PM ET

Accepted

Dec 14, 4:05 PM ET

Size

6.4 KB

Accession

0000899243-18-031054

Insider Transaction Report

Form 4
Period: 2018-12-12
Verner Erik J.
V.P., Chemistry Research
Transactions
  • Award

    Stock Option (Right to Buy)

    2018-12-1250,00050,000 total
    Exercise: $5.94Exp: 2028-12-12Common Stock (50,000 underlying)
Holdings
  • Common Stock, $0.0001 par value

    63,773
Footnotes (2)
  • [F1]A portion of these shares is subject to a right of repurchase held by the Issuer.
  • [F2]The underlying shares subject to the option vest and become exercisable as to one-forty eighth (1/48th) of the shares subject to the option in successive, equal monthly installments measured from December 12, 2018, subject to Reporting Person's continued service relationship with the Issuer on each such vesting date.

Issuer

Corvus Pharmaceuticals, Inc.

CIK 0001626971

Entity typeother

Related Parties

1
  • filerCIK 0001664488

Filing Metadata

Form type
4
Filed
Dec 13, 7:00 PM ET
Accepted
Dec 14, 4:05 PM ET
Size
6.4 KB